USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the Western European Next Generation Sequencing (NGS) Market
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
RELEASE DATE
11-Jun-2014
11-Jun-2014
REGION
Global
Global
Research Code: MA03-01-00-00-00
SKU: LS00098-GL-MR_16939
$4,950.00
In stock
SKU
LS00098-GL-MR_16939
Description
This study explores Western Europe’s dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 2014–2018 forecast period. A list of key sequencing service providers for each country or region is included.
Table of Contents
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
Market Definitions
Evolution of Molecular Genetic Testing
DNA Testing Ecosystem—Where Does NGS Fit?
Market Age
Market Segmentation
Western European Market Perspective
Defining Healthcare Trends in the Future
Procurement Process
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Market Restraints
Market Impact of Top 8 Trends
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Percent Revenue Forecast by Product Type
Revenue Forecast by Product Type
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Installed Base by Country
Number of Facilities
Market Outlook in Western Europe
Percent Revenue Forecast by Reagent Segment
Revenue Forecast by Reagent Segment
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Western European NGS Instruments—Market Share
Western European NGS Instruments—Market Share Analysis
Western European NGS Instruments—Market Share Analysis (continued)
Western European NGS Instruments—Market Share Analysis (continued)
Illumina—Overview
Product Analysis—Illumina
Applications
Life Technologies—Overview
Product Analysis—Life Technologies
Applications
Roche (454 Life Sciences)—Overview
Product Analysis—Roche
Applications
Pacific Biosciences—Overview
Product Analysis—Pacific Biosciences
Applications
Top Competitors
Top Competitors (continued)
Top Competitors (continued)
Top Competitors (continued)
Market Analysis
Western Europe Key Findings
PEST Analysis
Percent Sales Breakdown by Country
UK—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Germany—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
France—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Spain—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Italy—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
Benelux—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Scandinavia—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
The Last Word—3 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
List of Commercial Providers for Genetic Tests
List of Commercial Providers for Genetic Tests (continued)
List of Commercial Providers for Genetic Tests (continued)
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Additional Sources of Information
Market Engineering Methodology
Learn More—Next Steps
Popular Topics
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and global prevalence by region and country. Key market developments since Q1 2013 and key companies to watch are also included. This research service is an update of the 2013 research service titled Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | MA03-01-00-00-00 |
| Is Prebook | No |